Secondary analysis of the A-PLUS RCT (29,236 patients in labour): azithromycin's reduction in maternal infection did not vary by time from dose to delivery (RR 0.71 for both 12 h or less and over 12 h); no neonatal infection benefit at any interval.
Secondary analysisn = 29,236
Boelig et al. Timing of Prophylactic Intrapartum Azithromycin Administration and Efficacy in Prevention of Maternal and Infant Infections: A Secondary Analysis of a Randomized Controlled Trial